Welcome to our dedicated page for Thc Therapeutics news (Ticker: THCT), a resource for investors and traders seeking the latest updates and insights on Thc Therapeutics stock.
THC Therapeutics, Inc. reports corporate developments tied to its legal and regulated cannabis business. The company uses a strategic acquisition model to build a portfolio of revenue-producing cannabis assets, including STHoldings Group LLC and its SugarTop Buddery brand in Oregon.
Recurring THCT news covers acquisition activity, portfolio optimization, operating updates across its state markets, shareholder voting matters, capital-structure disclosure, and operating and financial results. Earlier company updates also documented management, consulting, financing, and market-entry initiatives connected to cannabis, alternative therapies, and health-related products.
THC Therapeutics, Inc. (THCT) announced its partnership with Milestone Management Services to enhance corporate communications and investor awareness. Milestone's CEO emphasized the growing investor interest in sectors like cannabis and technology. Brandon Romanek, CEO of THCT, highlighted that this collaboration will improve deal flow and capital raising efforts. The company is leveraging its patented dHydronator technology, which significantly reduces cannabis drying time, and is actively seeking strategic partnerships to increase shareholder value.
THC Therapeutics, Inc. (THCT) has successfully acquired significant amounts of physical silver at a low premium above spot price, leveraging the Founder & Chairman’s extensive experience in the precious metals market.
Brandon Romanek, with 15 years in the industry, emphasized the opportunity to purchase physical silver amid market manipulation by major banks. The company aims to increase its holdings, anticipating a shift towards physical silver trading. This acquisition aligns with THCT's strategy to enhance its precious metals and digital currency assets, positioning the firm well in the evolving market.
THC Therapeutics, Inc. (THCT) has joined the Las Vegas Medical Marijuana Association (LVMMA) to enhance its growth strategy by leveraging connections within the cannabis industry. The company plans to raise up to $75 million through a Reg A+ offering to fund its expansion. CEO Parker Mitchell expressed enthusiasm about the opportunities this association will bring. THC Therapeutics focuses on the dHydronator®, a technology that significantly reduces cannabis drying time from 10-14 days to less than 14 hours, while also exploring partnerships in cannabis-testing and wellness sectors.